First New Drug for Liver Cancer in a Decade: Regorafenib First New Drug for Liver Cancer in a Decade: Regorafenib
The FDA has approved an expanded indication for regorafenib to include hepatocellular carcinoma, making it the first drug to be approved for this cancer in a decade.FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Hematology | Hepatocellular Carcinoma | Liver | Liver Cancer | Urology & Nephrology